Mechanism and recent progress of gastric cancer in immunological checkpoint inhibitors / 实用肿瘤学杂志
Practical Oncology Journal
;
(6): 371-375, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-752871
ABSTRACT
The treatment of gastric cancer is limited and the prognosis is poor. Tumor immunotherapy has been an effective new treatment for cancer in addition to surgery,chemotherapy,radiotherapy and targeted therapy because of its remarkable survival benefit. As one of the methods of tumor immunotherapy,immunological checkpoint inhibitors have been approved for the treatment of various tumors,suggesting that the era of gastric cancer immunotherapy has arrived. This article describes the mechanism of action and related research progress of immunological checkpoint inhibitors in immunotherapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Practical Oncology Journal
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS